The Relationship Between Illness Perception and Medication Adherence in Hypertensive Patients Attending the General Out-Patient Clinics, Ekiti State University Teaching Hospital, South-West Nigeria
Main Article Content
Abstract
Background: Optimal blood pressure control has been shown to be associated with good adherence to medications and patient’s perception. This study sought to assess the relationship between illness perception and medication adherence of patients with hypertension with a view to improving the quality of care and medication adherence among the patients attending the outpatient clinic in Ekiti State.
Methods: A hospital-based cross-sectional study was conducted among 381 adult patients with hypertension who had been on antihypertensive medications for at least three months. A systematic random sampling method was used and a semi-structured interviewer questionnaire was administered to obtain information. Respondents’ illness perception was measured, using the Adapted (BIPQ), while the medication adherence was measured using MMAS-8. The data collected was analysed using SPSS version 20.
Results: The mean age of respondents was 62.30±3.84, with 54.9% reported moderate illness perception, 88.5% high illness perception, and 51.2% had good adherence to their medications. Respondents with moderate to high illness perception were about 7.84 and 3.21 times respectively, more likely to have good medication adherence than those with low illness perception. The significant predictors of medication adherence identified were sex, ethnicity, education, occupation, and marital status. There was a positive statistically significant relationship between respondents with moderate to high illness perception and good medication adherence (χ2 = 15.32, p= 0.003).
Conclusion: Clinicians should take cognizance of health and illness behaviours of their patients to reinforce patient perception and educate them on how a positive perception to their illness can enhance their antihypertensive adherence.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to editor@tnhjph.com.
How to Cite
References
1.World health organization: A global brief on hypertension: Silent killer, global public health crisis (world health day 2013) Geneva: WHO 2013
2.Njoku PO, Enomina M, Obehigbe EE, Mbah IO, Okoro EO, Essen ME, et al. Pattern of non-communicable diseases seen in a tertiary hospital in Keffi, North Central Nigeria. Nig J Cardiol 2019;16(1):60-65.
3.Ogah OS, Okpechi I, Chukwuonye II, Akinyemi JO, Onwubere BJ, Falase AO, et al. Blood pressure, prevalence of hypertension and hypertension related complications in Nigerian Africans: A review. World J Cardiol. 2012;4(12):327-340.
4.Okwuonu CG, Ojimadu NE, Okaka EI, Akemokwe FM. Patient-related barriers to hypertension control in a Nigerian population. Int J Gen Med. 2014;7:345-353.
5.Akintunde AA, Akintunde TS. Antihypertensive medications adherence among Nigerian hypertensive subjects in a specialist clinic compared to a general outpatient clinic. Ann Med Health Sci Res 2015;5(3):173-178.
6.Agbor VN, Takah NF, Aminde LN. Prevalence and factors associated with medication adherence among patients with hypertension in sub-Saharan Africa: protocol for a systematic review and meta-analysis. BMJ Open.2018;8(3):e020715.
7.Shahin W, Kennedy G, Stupans I. The impact of personal and cultural beliefs on medication adherence of patients with chronic illnesses: a systematic review. Patient Prefer Adherence. 2019;13:1019-1035.
8.Leventhal H, Meyer D, Nerenz D. The common sense representation of illness danger. In S.E. Rachman (Ed.), Medical Psychology. 1980;2:7-30.
9.Broadbent E, Petrie KJ, Main J. The Brief Illness Perception Questionnaire. Journal of Psychosomatic Research 2006;60(6):631–637.
10.Hsiao CY, Chang C, Chen CD. An investigation on illness perception and adherence among hypertensive patients. Kaohsiung Journal of Medical Sciences 2012;28(8):442-447.
11.Ekiti State Directorate of ICT. Available from ekitistate.gov.ng/about-Ekiti/population-figures. Accessed 23/09/18.
12.PopulationStat. Ado-Ekiti, Nigeria Population. Accessed at https://populationstat.com/nigeria/ado-ekiti. on 12th august, 2020.
13.Araoye MO. Subject selection: sample size determination. In: MO Araoye, editor. Research methodology with statistics for health and social sciences. Nathadex 2003;1:117-118.
14.Rajpura J, Nayak R. Medication adherence in a sample of elderly suffering from hypertension: Evaluating the influence of illness perceptions, treatment beliefs and illness burden. Journal of Managed Care Pharmacy 2014;20(1):58-65.
15.Ibrahim OA, Olaniyan FA, Sule AG, Ibrahim BY. Socio-demographic and clinical factors affecting adherence to antihypertensive medications and blood pressure control among patients attending the family practice clinic in a tertiary hospital in northern Nigeria. Nigerian Journal of Family Practice. 2018;9(1):39-49
16.Rasaq OS, Sanni AM, Odeigah OL, Abdullateef GS, Issa BA, Lawal SI, et al. Adherence to Antihypertensive medications and associated factors among patients in a Nigerian family practice setting. Ijmrps 2015;2(5):2394-9414
17.Norfazilah A, Samuel A, Law P, Ainaa A, Asmawati MN. Illness perception among hypertensive patients in primary care centre UKMMC. Malays Fam Physician. 2013;8(3):19-25.
18.Saarti S, Hajj A, Karam L, Jabbour H, Sarkis A, El Osta N, et al. Association between adherence, treatment satisfaction and illness perception in hypertensive patients. Journal of Human Hypertension. 2016;30(5):341-345
19.Adisa R, Ilesanmi OA, Fakeye TO. Treatment adherence and blood pressure outcome among hypertensive out patients in two tertiary hospitals in Sokoto, Northwestern Nigeria. BMC Cardiovasc Discord. 2018;25:194.
20.Kucukarslan SN. A review of published studies of patients' illness perceptions and medication adherence: Lessons learned and future directions. Research in Social and Administrative Pharmacy. 2012;8(5):371-382
21.Nivedita S. Illness perception and coping among hypertension patients. Research Journal of Recent Sciences 2015;4:270-273.
22.Kaplan NM, Victor RG. Kaplan’s Clinical Hypertension. 11th ed. Philadelphia, USA: Lippincott Williams & Wilkins (LWW); 2014.1-461.
23.Ibekwe R. Modifiable risk factors of hypertension and socio-demographic profile in Oghara, Delta State; prevalence and correlates. Ann Med Health Sci Res 2015;5:71-77.
24.Rahman AR, Wang JG, Kwong GM, Morales DD, Sritara P, Sukmawan R. Perception of hypertension management by patients and doctors in Asia: potential to improve blood pressure control. Asia Pacific Family Medicine. 2015;14(1):2
25.Osamor PE, Owummi BE. Factors associated with treatment compliance in hypertension in south west Nigeria. J Health Population Nutr. 2011;29:619-628.
26.Mukora-Mutseyekwa FN, Chadambuka EM. Drug adherence behaviour among hypertensive out-patients at a tertiary health institution in Manicaland province, Zimbabwe. Patient Prefer Adherence. 2013;7(3):65–70.
27.Boima V, Ademola AD, Odusola AO, Agyekum F, Nwafor CE, Cole H, et al. Factors associated with medication non-adherence among hypertensive in Ghana and Nigeria. Int J Hypertens. 2015;2015:1-8
28.Iloh GUP, Ofoedu JN, Njoku PU, Amadi AN, Godswill-Uko EU. Medication adherence and blood pressure control amongst adults with primary hypertension attending a tertiary hospital primary care clinic in Eastern Nigeria. Afr Journal of Primary Health Care and Family Medicine 2013;5(1):123-126.
29.Zyoud SH, Al-Jabi SW, Sweileh WM, Morisky DE. Relationship of treatment satisfaction to medication adherence. Findings from a cross-sectional survey among hypertensive patients in Palestine. Health Qual Life Outcomes. 2013;11:191.
30.Kretchy IA, Owusu-Daaku FT, Danquah S. Locus of control and antihypertensive medication adherence in Ghana. Pan Afr Med J. 2014;17Suppl 1:13
31.Abegaz TM, Shehab A, Gebreyohannes EA, Bhagavathula AS, Elnour AA. Nonadherence to antihypertensive drugs. a systematic review and meta-analysis. Medicine.2017; 96(4): e5641.
32.Ajayi EA, Adeoti AO, Ajayi IA, Ajayi AO, Adeyeye VO. Adherence to antihypertensive medications and some of its clinical implications in patients seen at a tertiary hospital in Nigeria. IOSR J Dental Med Sci. 2013;8(4):36-40.
33.Ambaw DA, Alemie GA, Yohannes SM, Mengesha ZB. Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondor Hospital, Northwest Ethiopia. BMC Public Health 2012;12:282.
34.Dennis T, Meera NK, Binny K, Sekhar MS, Kishore G, Sasidharan S. Medication adherence and associated barriers in hypertension management in India. Cardiovascular Disease Prevention and Control. 2011;6:9-13.
35.Ramli A, Ahmad NS, Paraidathathu T. Medication adherence among hypertensive patients of primary health clinics in Malaysia. Patient Preference and Adherence 2012;6:613-622.
36.Leventhal H, Phillips LA, Burns E. The Common-Sense Model of Self-Regulation (CSM): a dynamic framework for understanding illness self-management. J Behav Med. 2016;39(6):935-946
37.Ross S, Walker A, MacLeod MJ. Patient compliance in hypertension: role of illness perceptions and treatment beliefs. J Hum Hypertens 2004;18(9):607-613.
38.Chen SL, Tsai JC, Lee WL. The impact of illness perception on adherence to therapeutic regimens of patients with hypertension in Taiwan. J ClinNurs.2009;18:2234-2244.
39.Spikes T, Higgins M, Lewis T, Dunbar SB. The associations among illness perceptions, resilient coping, and medication adherence in young adult hypertensive black women. J ClinHypertens. 2019;21:1695-1714
40.Farmer KC. Leventhal's common-sense model and medication adherence. Research in Social and Administrative Pharmacy. 2012;8(5):355-356.